pathologies, thus providing important information of changes occurring within the white matter of the brain. To date the application of MRS has been primarily limited to proton spectroscopy, which can resolve only a handful of molecules of sufficient abundance in the brain (e.g., choline, and N-acetylaspartate, constituents of white matter and grey matter, respectively) to be identified using standard clinical scanners with field strengths of 1.5 and 3 Tesla (T).
